Nafarelinkezelés endometriosisban

Translated title of the contribution: Use of nafarelin in the treatment of endometriosis

Attila Keresztúri, József Daru, A. Pál

Research output: Contribution to journalArticle

Abstract

Endometriosis is a frequent occuring gynaecological disease associated with dysmenorrhoea, pelvic pain and infertility. The aim of the authors' study was to evaluate the relative safety and efficacy of nafarelin (Synarel, SYNTEX) as primary treatment for the disease as well as to obtain data on the ovarian and liver function during, and after the treatment. They used the "gold standard" in the management of the disease. They performed laparoscopy 122 patients who had either of the above listed complaints and found endometriosis in 30 cases. All the 30 patients treated for six months and followed up for at least an additional 6 months. The serum oestradiol levels decreased to the postmenopausal level at the 1st month of treatment, and were back to the normal level after the sixth month of the treatment. There were no significant changes in the blood chemistry, liver function and no major side-effects occured. This treatment presents a favourable alternate approach in the management of endometriosis.

Original languageHungarian
Pages (from-to)107-111
Number of pages5
JournalMagyar Noorvosok Lapja
Volume65
Issue number2
Publication statusPublished - 2002

Fingerprint

Nafarelin
Endometriosis
Therapeutics
Dysmenorrhea
Pelvic Pain
Liver
Disease Management
Laparoscopy
Infertility
Estradiol
Safety
Serum

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Keresztúri, A., Daru, J., & Pál, A. (2002). Nafarelinkezelés endometriosisban. Magyar Noorvosok Lapja, 65(2), 107-111.

Nafarelinkezelés endometriosisban. / Keresztúri, Attila; Daru, József; Pál, A.

In: Magyar Noorvosok Lapja, Vol. 65, No. 2, 2002, p. 107-111.

Research output: Contribution to journalArticle

Keresztúri, A, Daru, J & Pál, A 2002, 'Nafarelinkezelés endometriosisban', Magyar Noorvosok Lapja, vol. 65, no. 2, pp. 107-111.
Keresztúri A, Daru J, Pál A. Nafarelinkezelés endometriosisban. Magyar Noorvosok Lapja. 2002;65(2):107-111.
Keresztúri, Attila ; Daru, József ; Pál, A. / Nafarelinkezelés endometriosisban. In: Magyar Noorvosok Lapja. 2002 ; Vol. 65, No. 2. pp. 107-111.
@article{90051b61735c49f9a5206b73f988f273,
title = "Nafarelinkezel{\'e}s endometriosisban",
abstract = "Endometriosis is a frequent occuring gynaecological disease associated with dysmenorrhoea, pelvic pain and infertility. The aim of the authors' study was to evaluate the relative safety and efficacy of nafarelin (Synarel, SYNTEX) as primary treatment for the disease as well as to obtain data on the ovarian and liver function during, and after the treatment. They used the {"}gold standard{"} in the management of the disease. They performed laparoscopy 122 patients who had either of the above listed complaints and found endometriosis in 30 cases. All the 30 patients treated for six months and followed up for at least an additional 6 months. The serum oestradiol levels decreased to the postmenopausal level at the 1st month of treatment, and were back to the normal level after the sixth month of the treatment. There were no significant changes in the blood chemistry, liver function and no major side-effects occured. This treatment presents a favourable alternate approach in the management of endometriosis.",
keywords = "Endometriosis, GnRH analogue, Nafarelin",
author = "Attila Kereszt{\'u}ri and J{\'o}zsef Daru and A. P{\'a}l",
year = "2002",
language = "Hungarian",
volume = "65",
pages = "107--111",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "2",

}

TY - JOUR

T1 - Nafarelinkezelés endometriosisban

AU - Keresztúri, Attila

AU - Daru, József

AU - Pál, A.

PY - 2002

Y1 - 2002

N2 - Endometriosis is a frequent occuring gynaecological disease associated with dysmenorrhoea, pelvic pain and infertility. The aim of the authors' study was to evaluate the relative safety and efficacy of nafarelin (Synarel, SYNTEX) as primary treatment for the disease as well as to obtain data on the ovarian and liver function during, and after the treatment. They used the "gold standard" in the management of the disease. They performed laparoscopy 122 patients who had either of the above listed complaints and found endometriosis in 30 cases. All the 30 patients treated for six months and followed up for at least an additional 6 months. The serum oestradiol levels decreased to the postmenopausal level at the 1st month of treatment, and were back to the normal level after the sixth month of the treatment. There were no significant changes in the blood chemistry, liver function and no major side-effects occured. This treatment presents a favourable alternate approach in the management of endometriosis.

AB - Endometriosis is a frequent occuring gynaecological disease associated with dysmenorrhoea, pelvic pain and infertility. The aim of the authors' study was to evaluate the relative safety and efficacy of nafarelin (Synarel, SYNTEX) as primary treatment for the disease as well as to obtain data on the ovarian and liver function during, and after the treatment. They used the "gold standard" in the management of the disease. They performed laparoscopy 122 patients who had either of the above listed complaints and found endometriosis in 30 cases. All the 30 patients treated for six months and followed up for at least an additional 6 months. The serum oestradiol levels decreased to the postmenopausal level at the 1st month of treatment, and were back to the normal level after the sixth month of the treatment. There were no significant changes in the blood chemistry, liver function and no major side-effects occured. This treatment presents a favourable alternate approach in the management of endometriosis.

KW - Endometriosis

KW - GnRH analogue

KW - Nafarelin

UR - http://www.scopus.com/inward/record.url?scp=0036223444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036223444&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036223444

VL - 65

SP - 107

EP - 111

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 2

ER -